These molecules may be relevant for ameliorating synapse-related deficits in motor neuron diseases; indeed, we show that dipyridamole rescues defects in the chodl mutant and in a zebrafish SMA model. This evidence concerns the gene CHODL and proximal spinal muscular atrophy.